These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29784844)

  • 21. Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou Q; Onufrak NJ; Wirth V; Chen K; Wang J; Forrest A; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.
    Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
    Intensive Care Med; 2006 Dec; 32(12):1970-8. PubMed ID: 16957901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs.
    Borgatta B; Gattarello S; Mazo CA; Imbiscuso AT; Larrosa MN; Lujàn M; Rello J
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2155-2163. PubMed ID: 28624864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of antibiotic prophylaxis against ventilator-associated pneumonia.
    Mirtalaei N; Farazi A; Ebrahimi Monfared M; Jokar A
    J Hosp Infect; 2019 Mar; 101(3):272-275. PubMed ID: 30179656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of selective digestive decontamination as a natural experiment to evaluate topical antibiotic prophylaxis and cephalosporin use as population-level risk factors for enterococcal bacteraemia among ICU patients.
    Hurley JC
    J Antimicrob Chemother; 2019 Oct; 74(10):3087-3094. PubMed ID: 31355880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower respiratory tract microbial composition was diversified in Pseudomonas aeruginosa ventilator-associated pneumonia patients.
    Qi X; Qu H; Yang D; Zhou L; He YW; Yu Y; Qu J; Liu J
    Respir Res; 2018 Jul; 19(1):139. PubMed ID: 30049266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel porcine model of ventilator-associated pneumonia caused by oropharyngeal challenge with Pseudomonas aeruginosa.
    Li Bassi G; Rigol M; Marti JD; Saucedo L; Ranzani OT; Roca I; Cabanas M; Muñoz L; Giunta V; Luque N; Rinaudo M; Esperatti M; Fernandez-Barat L; Ferrer M; Vila J; Ramirez J; Torres A
    Anesthesiology; 2014 May; 120(5):1205-15. PubMed ID: 24618700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials.
    Siempos II; Ntaidou TK; Falagas ME
    Crit Care Med; 2010 Mar; 38(3):954-62. PubMed ID: 20016381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable polymyxin B susceptibility to Pseudomonas aeruginosa and Acinetobacter spp. despite persistent recovery of these organisms from respiratory secretions of patients with ventilator-associated pneumonia treated with this drug.
    Zavascki AP; Li J; Nation RL; Superti SV; Barth AL; Lutz L; Ramos F; Boniatti MM; Goldani LZ
    J Clin Microbiol; 2009 Sep; 47(9):3064-5. PubMed ID: 19587305
    [No Abstract]   [Full Text] [Related]  

  • 30. Pseudomonas aeruginosa colonization enhances ventilator-associated pneumonia-induced lung injury.
    Tsay TB; Jiang YZ; Hsu CM; Chen LW
    Respir Res; 2016 Aug; 17(1):101. PubMed ID: 27506464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rapid
    Wang K; Chen YQ; Salido MM; Kohli GS; Kong JL; Liang HJ; Yao ZT; Xie YT; Wu HY; Cai SQ; Drautz-Moses DI; Darling AE; Schuster SC; Yang L; Ding Y
    Open Biol; 2017 Sep; 7(9):. PubMed ID: 28878043
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparision of risk factors and pathogens in patients with early- and late-onset ventilator-associated pneumonia in intensive care unit].
    Liang YJ; Li ZL; Wang L; Liu BY; Ding RY; Ma XC
    Zhonghua Nei Ke Za Zhi; 2017 Oct; 56(10):743-746. PubMed ID: 29036955
    [No Abstract]   [Full Text] [Related]  

  • 35. Polymicrobial Ventilator-Associated Pneumonia: Fighting In Vitro Candida albicans-Pseudomonas aeruginosa Biofilms with Antifungal-Antibacterial Combination Therapy.
    Rodrigues ME; Lopes SP; Pereira CR; Azevedo NF; Lourenço A; Henriques M; Pereira MO
    PLoS One; 2017; 12(1):e0170433. PubMed ID: 28114348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk factors and etiological analysis of ventilator-associated pneumonia: three year's cases analysis of intensive care unit in county hospital].
    Hu Z; Zhou S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Oct; 30(10):933-938. PubMed ID: 30439311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and clinical outcomes of episodes of ventilator-associated pneumonia caused by SPM-1-producing and non-producing imipenem-resistant Pseudomonas aeruginosa.
    Furtado GH; Gales AC; Perdiz LB; Santos AF; Medeiros EA
    Rev Soc Bras Med Trop; 2011 Oct; 44(5):604-6. PubMed ID: 22031077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does selective digestive decontamination prevent ventilator-associated pneumonia in trauma patients?
    Chaari A; Zribi E; Dammak H; Ghadoun H; Chtara K; Sfar S; Bahloul M; Bouaziz M
    Am J Ther; 2014; 21(6):470-6. PubMed ID: 23567785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discrepancies in Control Group Mortality Rates Within Studies Assessing Topical Antibiotic Strategies to Prevent Ventilator-Associated Pneumonia: An Umbrella Review.
    Hurley JC
    Crit Care Explor; 2020 Jan; 2(1):e0076. PubMed ID: 32166296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
    Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.